Related Experiment Video
Updated: Mar 18, 2026
Drug-Induced Sleep Endoscopy DISE with Target Controlled Infusion TCI and Bispectral Analysis in Obstructive Sleep Apnea
Published on: December 6, 2016
Pediatric Sleep Apnea Syndrome: An Update
Zhenhong Li1, Jocelyn Celestin1, Richard F Lockey2
1Division of Allergy and Immunology, Department of Internal Medicine, Albany Medical College, Albany, NY.
Insights
Obstructive sleep apnea syndrome (OSAS) is common in children, often caused by airway issues. Early diagnosis and treatment, like surgery for enlarged tonsils, are crucial for preventing health problems.
Area of Science:
- Pediatrics
- Sleep Medicine
- Otolaryngology
Background:
- Obstructive sleep apnea syndrome (OSAS) is a prevalent childhood condition, affecting 1%-5% of children aged 2-8 years.
- OSAS can originate from central neurologic or obstructive causes, with obstructive being the most common (>95%).
- Untreated OSAS is linked to significant comorbidities, including cardiovascular, metabolic, neurocognitive, and behavioral issues.
Purpose of the Study:
- To review the prevalence, pathophysiology, clinical presentation, diagnosis, and treatment of obstructive sleep apnea syndrome in children.
- To highlight the importance of screening for OSAS in pediatric patients.
- To discuss current treatment strategies for pediatric OSAS.
Main Methods:
- Clinical evaluation, including history and physical examination, as recommended by the American Academy of Pediatrics.
- Diagnostic confirmation through polysomnography.
- Review of existing literature on pediatric OSAS.
Main Results:
- OSAS is a common condition in children with diverse pathophysiologic origins.
- Cardiovascular, metabolic, neurocognitive, and behavioral problems are potential comorbidities.
- Treatment varies based on age, medical status, polysomnography results, and the presence of upper airway obstruction.
Conclusions:
- Early screening and diagnosis of pediatric OSAS are essential.
- Surgical intervention (adenoidectomy, tonsillectomy) is a primary treatment for airway obstruction.
- Pharmacotherapy may be beneficial for mild cases, while surgery addresses underlying anatomical issues.
Abstract:
Obstructive sleep apnea syndrome (OSAS) may be central neurologic (<5%) or obstructive (>95%) in origin and is a relatively prevalent condition in children. It affects 1%-5% of children aged 2-8 years and is caused by a variety of different pathophysiologic abnormalities. Cardiovascular, metabolic, and neurocognitive comorbidities can occur in both children and adults when left untreated. It also can cause severe behavioral problems in children. The American Academy of Pediatrics recommends that all children be screened with an appropriate history and physical examination for symptoms and signs suggestive of OSAS. The diagnosis is primarily made clinically and confirmed by polysomnographic findings. Treatment depends on the child's age, underlying medical problems, polysomnography findings, and whether or not there is upper airway obstruction usually secondary to enlarged adenoids and/or tonsils, allergic and nonallergic rhinitis, acute and chronic sinusitis, and other upper airway pathology. If enlarged adenoid or tonsils or both conditions exist, an adenoidectomy, tonsillectomy, or adenotonsillectomy remains the treatment of choice. Pharmacotherapy of OSAS has shown some effect in children with mild symptoms. This paper reviews the prevalence, pathophysiology, clinical presentation, diagnosis, and treatment of OSAS.
Related Concept Videos
01:21Sleep Apnea
The condition is more prevalent among...
01:22Cardiopulmonary Resuscitation II: ACLS Airway Management
01:29Chronic Obstructive Pulmonary Disease-V: Management
Smoking Cessation
01:23Mechanical Ventilation III: Noninvasive Ventilation
Noninvasive Positive-Pressure Ventilation...
01:17Other Pulmonary Disorders
01:20Chronic Obstructive Pulmonary Disease-I: Introduction